The nation of Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (272 million pounds) spanning five years over the United States' demand for confidential data.
This rejection was revealed after a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official representative later stated that the US was demanding access to biological samples for scientific study and profit but was unwilling to share the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further dialogue to reach a deal agreeable to both sides so the nation's critical HIV programme can be sustained.
Broader Background
This rejection follows a comparable situation in Kenya, where a high court halted a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the US government, but Trump argued its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost transparency and accountability.
Based on statements, 16 nations in Africa have to date signed similar agreements, constituting over $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," his statement read.
"In essence, our country would provide the basic resources for medical research with no assurance that the end products would be available to our population should a new health crisis arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting systems previously set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This framework is intended to ensure that when a country contributes its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome ongoing discussions with our American counterparts on how future co-operation might be designed in a way that respects the sovereignty and interests of both nations."
Medical Community Response
A leading public health body stated it acknowledged the government's concerns, but recommended that talks must proceed since much of the nation's HIV programmes relied on external financing.
"If specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," the group said.
The halted deal underscores the complex challenges between receiving vital international aid and protecting a country's data in an increasingly data-driven world.